Clinical trials
Terminated Phase 2 Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
119 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 11 |
| 2005 | 8 |
| 2006 | 13 |
| 2007 | 9 |
| 2008 | 4 |
| 2009 | 10 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 6 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 119 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 14 |
| Masonic Cancer Center, University of Minnesota | 5 |
| Massachusetts General Hospital | 5 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 5 |
| Eastern Cooperative Oncology Group | 4 |
| National Cancer Institute (NCI) | 3 |
| Northwestern University | 3 |
| OHSU Knight Cancer Institute | 3 |
| Seagen Inc. | 3 |
| ADC Therapeutics S.A. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 119 |
| Leukemia | 40 |
| Lymphoma, Non-Hodgkin | 34 |
| Lymphoma, Large B-Cell, Diffuse | 28 |
| Lymphoma, Follicular | 27 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 25 |
| Hodgkin Disease | 23 |
| Myelodysplastic Syndromes | 23 |
| Multiple Myeloma | 22 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 21 |
Trials
Showing 1 to 25 of 119. Each trial links to its page on Pharma Observatory.
19 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.